BioNxt Solutions Inc.
BNXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.26% | 32.15% | 48.92% | 51.37% | 36.10% |
| Total Depreciation and Amortization | -63.59% | -53.79% | -43.33% | -24.18% | -16.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.79% | -26.90% | -79.46% | -82.23% | -68.69% |
| Change in Net Operating Assets | -93.20% | 65.47% | 2,844.10% | 252.24% | 203.18% |
| Cash from Operations | 29.32% | 42.24% | 38.96% | 32.17% | 32.83% |
| Capital Expenditure | -- | -- | 28.90% | 31.26% | -3,423.81% |
| Sale of Property, Plant, and Equipment | -55.40% | -81.50% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 33.56% | -43.70% | 330.85% | 323.17% | 1,866.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -333.61% | -317.49% | 99.73% | 99.47% | 93.22% |
| Issuance of Common Stock | -61.57% | -69.10% | -47.36% | -42.77% | -61.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -715.78% | 36.94% | 43.99% | 40.07% | 55.41% |
| Cash from Financing | 25.04% | -50.89% | -36.17% | -35.90% | -61.15% |
| Foreign Exchange rate Adjustments | 254.55% | 140.00% | 33.33% | -70.97% | -145.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.67% | -250.40% | 67.37% | 84.92% | -5,154.89% |